Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
- Resource Type
- Article
- Source
- The Lancet; January 2019, Vol. 393 Issue: 10167 p143-155, 13p
- Subject
- Language
- ISSN
- 01406736; 1474547X